Antiviral Agent Pharmaceutical Raw Materials CAS 3083-77-0 Spongouridine

• Post Date:

  Jan 18,2018

• Expiry Date:

  Jul 17,2018

• Detailed Description:

  Product Name: Spongouridine
  Synonyms: 1-beta-d-arabinofuranosyl-uraci;3h)-pyrimidinedione,1-beta-d-arabinofuranosyl-4(1h;arauridine;spongouridin;uracilarabinoside;ARABINOSYL-URACIL;ARABINOFURANOSYLURACIL;ARA-U
  Spongouridine CAS: 3083-77-0
  Spongouridine MF: C9H12N2O6
  Spongouridine MW: 244.2
  Spongouridine EINECS: 221-386-9
  Spongouridine Product Categories: Bases & Related Reagents;Carbohydrates & Derivatives;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals
  Spongouridine Melting point : 220-222°C
  Spongouridine Storage temp. : 2-8°C
  Chemical Properties : White to Off-White Solid
  Usage : Antiviral agent. Used for the treatment of severe acute respiratory syndrome (SARS).
  
  Spongouridine Description
  Vidarabine or 9-β-D-arabinofuranosyladenine (ara-A) is an antiviral drug which is active against herpes simplex and varicella zoster viruses.
  
  Clinical indication
  Vidarabine is an antiviral, active against herpes viruses, poxviruses, rhabdoviruses, hepadnaviruses and some RNA tumour viruses. A 3% ophthalmic ointment Vira-A is used in the treatment of acute keratoconjunctivitis and recurrent superficial keratitis caused by HSV-1 and HSV-2. Vidarabine is also used to treat herpes zoster in AIDS patients, reducing lesions formation and the duration of viral shedding. Many of the previous uses of vidarabine have been superseded by acyclovir, due to the hospitalisation required for intra venous dosing, and acyclovir has a higher selectivity, lower inhibitory concentration and higher potency. Toxic side effects are rare, but have been reported with high concentrations of vidarabine, such as nausea, vomiting, leukopenia and thrombocytopenia in patients receiving high intravenous doses daily.
  

• Company:

  Wuhan Yuancheng Technology Co.,LTD     [ China ]        

• Contact:

  mariah

• Tel:

  15872388127

• Fax:

• Email:

  mariah@ycphar.com